PART 12 U.K.Amendment of Part 12 (dealings with medicinal products)

[F1 Amendment of regulation 255B (exception to Article 25 of Commission Regulation 2016/161: health care institutions) U.K.

196.   In regulation 255A(1), after “purpose of sale or supply,” insert “in Northern Ireland,”.]

Textual Amendments

F1 Regs. 196, 196A substituted for reg. 196 (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 150

Commencement Information

I1 Reg. 196 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1